期刊文献+

VEGFR2低表达的CRL2830细胞体外模型的建立和生物学特性研究

Establishment of CRL2830 Cell Model in Vitro with VEGFR2 Low Expression and Study of Its Biological Characteristics
下载PDF
导出
摘要 采用3-D培养和shRNA技术首次建立了VEGFR2低表达的人源性多囊肾CRL2830细胞体外模型,进一步考察该基因表达抑制对多囊肾细胞生物学特性的影响.研究结果表明:与亲本细胞相比,VEGFR2表达抑制虽然不影响细胞生长速度和侵袭能力,但能引起细胞形态明显改变,细胞和细胞核的体积增大,细胞容易形成团状结构;3-D培养结果表明VEGFR2低表达能显著延缓囊肿的生长速度,有效诱导囊肿细胞早期凋亡. An idea model of polycystic kidney cells CRL2830 with angiogenesls tactor receptor 2 (VEG- FR2) low expression was established by applying 3-D culture and shRNA technology, which can be applied to reveal the role of VEGFR2 in polycystic kidney disease. The change of biological characteristics in this cell line was observed,and the results have shown that, although VEGFR2 low expression does not affect cell growth and invasion, it can result in the volume increase of cell and nucleus and the enhancement of cell aggregation. Furthermore, the low expression of VEGFR2 can not only inhibit cyst growth but also efficiently induce early cell apoptosis in 3-D culture cells, compared with parental cells.
作者 刘斌 童春义
出处 《湖南大学学报(自然科学版)》 EI CAS CSCD 北大核心 2010年第9期65-68,共4页 Journal of Hunan University:Natural Sciences
基金 湖南大学'中央高校基本科研业务费专项资金资助项目'(2009-12 2009-20) 湖南大学人才引进资助项目
关键词 多囊肾 血管内皮生长因子 血管内皮生成因子受体2 囊肿 polycystic kidney vascular endothelial growth factor (VEGF) vascular endothelial growth factor receptor 2 (VEGFR2) cyst
  • 相关文献

参考文献14

  • 1GRANTHAM J J.Clinical practice:Autosomal dominant polycystickidney disease[J].N Engl J Med,2008,359:1477-1485.
  • 2WILSON P D,GOILAV B.Cystic disease of the kidney[J].Annu Rev Pathol,2007,2:341-368.
  • 3KASPAREIT-RIT TINGHAUSEN J,DEERBERG F,RAPP K G,et al.A new rat model for polycystic kidney disease of humans[J].Transplant Proc,1990,22:2582-2583.
  • 4STINGER K D,KOMERS R,OSMAN S A,et al.Gender hormones and the progression of experimental polycystic kidney disease[J].Kidney Int,2005,68:1729-1739.
  • 5ITO F,NAKAZAWA H,RYOJI O,et al.Cytokines accumulated in acquired renal cysts in long-term hemodialysis patients[J].Urol Int,2000,65:21-27.
  • 6NICHOLS M T,GIDEY E,MATZAKOS T,et al.Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid[J].Hepatology,2004,40:836-846.
  • 7FABRIS L,CADAMURO M,FIOROTTO R,et al.Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases[J].Hepatology,2006,43:1001-1012.
  • 8AMURA C R,BRODSKY K S,GROFF R,et al.VEGF receptor inhibition blocks liver cyst growth in pkd2(WS25/-) mice[J].Am J Physiol Cell Physiol,2007,293:419-428.
  • 9ZAFAR I,TAO Y X,FALK S,et al.Effect of statin and angiotensin-converting enzyme inhibition on structural and hemodynamic alterations in autosomal dominant polycystic kidney disease model[J].Am J Physiol Renal Physiol,2007,293:854-859.
  • 10TAO Y,KIM J,YIN Y,et al.VEGF receptor inhibition slows the progression of polycystic kidney disease[J].Kidney Int,2007,72:1358-1366.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部